SO-YOUNG INTERNATIONAL

So-Young Announces Receipt of Withdrawal of Buyer Group’s Going Private Proposal

21 Oct 2022 03:00:00 By Nasdaq GlobeNewswire

So-Young Reports Unaudited Second Quarter 2022 Financial Results

16 Aug 2022 02:30:00 By Nasdaq GlobeNewswire

So-Young to Report Second Quarter 2022 Financial Results on August 16, 2022

09 Aug 2022 03:00:00 By Nasdaq GlobeNewswire

So-Young Announces Receipt of Minimum Bid Price Notice from Nasdaq

18 Jul 2022 02:30:00 By Nasdaq GlobeNewswire

So-Young Reports Unaudited First Quarter 2022 Financial Results

23 May 2022 02:30:00 By Nasdaq GlobeNewswire

So-Young to Report First Quarter 2022 Financial Results on May 23, 2022

16 May 2022 03:30:00 By Nasdaq GlobeNewswire

So-Young Provides Update on Status under Holding Foreign Companies Accountable Act

10 May 2022 04:30:00 By Nasdaq GlobeNewswire

So-Young International Inc. Files Its Annual Report on Form 20-F

06 May 2022 02:21:30 By Nasdaq GlobeNewswire

So-Young Reports Unaudited Fourth Quarter and Fiscal Year 2021 Financial Results

25 Mar 2022 01:30:00 By Nasdaq GlobeNewswire

So-Young to Report Fourth Quarter and Full Year 2021 Financial Results on March 25, 2022

18 Mar 2022 02:00:00 By Nasdaq GlobeNewswire

HOOKIPA Announces First Patient Enrolled in Phase 2 Trial Evaluating HB-200 and Pembrolizumab for Treatment of Head and Neck Cancer and Reports FDA’s Fast Track Designation

18 Jan 2022 04:00:01 By Nasdaq GlobeNewswire

HOOKIPA Pharma to Present at the H.C. Wainwright BioConnect Conference

04 Jan 2022 04:00:01 By Nasdaq GlobeNewswire

HOOKIPA Pharma to Participate in the JMP Securities Hematology and Oncology Summit

03 Dec 2021 04:00:00 By Nasdaq GlobeNewswire

So-Young Announces Engagement of Legal and Financial Advisors to the Special Committee

03 Dec 2021 02:00:00 By Nasdaq GlobeNewswire

So-Young Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Company

22 Nov 2021 04:26:41 By Nasdaq GlobeNewswire

So-Young Reports Unaudited Third Quarter Financial Results

19 Nov 2021 02:30:00 By Nasdaq GlobeNewswire

HOOKIPA Pharma to Participate in Upcoming Stifel 2021 Virtual Healthcare Conference

12 Nov 2021 04:00:02 By Nasdaq GlobeNewswire

So-Young to Report Third Quarter 2021 Financial Results on November 19, 2021

11 Nov 2021 02:00:00 By Nasdaq GlobeNewswire

HOOKIPA Pharma Reports Third Quarter 2021 Financial Results and Recent Highlights

10 Nov 2021 03:29:55 By Nasdaq GlobeNewswire

HOOKIPA advances HB-200 program to Phase 2 and prioritizes oncology portfolio based on clinical data updates across its novel arenaviral platform

09 Nov 2021 13:01:01 By Nasdaq GlobeNewswire